Memantine for Prevention of Cognitive Decline in Patients With Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Cognitive Decline|Chemo-brain
Interventions: DRUG: Memantine
Sponsor: UNC Lineberger Comprehensive Cancer Center
Collaborators: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)